Helio Genomics Announces Strategic Commercial Partnership with Syneos Health® to Accelerate Nationwide Adoption of HelioLiver™, A Breakthrough AI-Powered Blood Test for Early Liver Cancer Detection
The End of the “Silent Epidemic”: How AI and Liquid Biopsies are Redefining Cancer Screening For decades, the fight against liver cancer has been a race against time—a race that patients often lose because the disease remains invisible until This proves too late. Hepatocellular carcinoma (HCC) is frequently termed a “silent epidemic” because it lacks … Read more